Cover Image

An optimal combination of four active components in Huangqin decoction for the synergistic sensitization of irinotecan against colorectal cancer

Abstract Background Irinotecan (CPT-11) is a first-line treatment for advanced colorectal cancer (CRC). Four components (baicalin, baicalein, wogonin, and glycyrrhizic acid) derived from Huangqin Decoction (HQD) have been proven to enhance the anticancer activity of CPT-11 in our previous study. Obj...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hongyan Zhou (Author), Dingxin Hu (Author), Xian Zhao (Author), Siyuan Qin (Author), Qiyao Nong (Author), Yuan Tian (Author), Zunjian Zhang (Author), Haijuan Dong (Author), Pei Zhang (Author), Fengguo Xu (Author)
Format:	Book
Published:	BMC, 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Quantitative Evaluation of the Compatibility Effects of Huangqin Decoction on the Treatment of Irinotecan-Induced Gastrointestinal Toxicity Using Untargeted Metabolomics
by: Zun-Jian Zhang, et al.
Published: (2017)

Synergistic Effect of Huangqin Decoction Combined Treatment With Radix Actinidiae chinensis on DSS and AOM-Induced Colorectal Cancer
by: Jianbo Huang, et al.
Published: (2022)

Pharmacometabolomic prediction of individual differences of gastrointestinal toxicity complicating myelosuppression in rats induced by irinotecan
by: Yiqiao Gao, et al.
Published: (2019)

Systems Pharmacology Based Strategy for Q-Markers Discovery of HuangQin Decoction to Attenuate Intestinal Damage
by: Xiao-min Dai, et al.
Published: (2018)

The effective combination therapies with irinotecan for colorectal cancer
by: Yun Chai, et al.
Published: (2024)

Translational Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Oxaliplatin and Irinotecan in Colorectal Cancer
by: Jinwei Zhu, et al.
Published: (2023)

Identification of GPR35-associated metabolic characteristics through LC-MS/MS-based metabolomics and lipidomics
by: Qiqing Zhang, et al.
Published: (2024)

Effect of Huangqin decoction on regulating intestinal flora in colitis mice characterized as inhibition of the NOD2-dependent pathway
by: Shaowei Huang, et al.
Published: (2022)

IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2008)

Prevention of ulcerative colitis by Huangqin decoction: reducing the intestinal epithelial cell apoptosis rate through the IFN-γ/JAK/ETS signalling pathway
by: Xiaowei Mo, et al.
Published: (2022)

Huangqin Tang Interference With Colitis Associated Colorectal Cancer Through Regulation of Epithelial Mesenchymal Transition and Cell Cycle
by: Xuran Ma, et al.
Published: (2022)

Determination of the synergistic anti-influenza effect of Huangqin Su tablet and Oseltamivir and investigation of mechanism of the tablet based on gut microbiota and network pharmacology
by: Xuran Cui, et al.
Published: (2023)

CAPECITABINE AND IRINOTECAN AS FIRST- LINE CHEMOTHERAPY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan Davidov
Published: (2010)

Evaluation of the Expression Profile of Irinotecan-Induced Diarrhea in Patients with Colorectal Cancer
by: Mashiro Okunaka, et al.
Published: (2021)

Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial β-glucuronidase
by: Bei Yue, et al.
Published: (2021)

Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer
by: Yu-Hsuan Liu, et al.
Published: (2023)

Combination of miR159 Mimics and Irinotecan Utilizing Lipid Nanoparticles for Enhanced Treatment of Colorectal Cancer
by: Rulei Yang, et al.
Published: (2024)

Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer
by: Xiaoying Hou, et al.
Published: (2021)

Population pharmacokinetics of intraperitoneal irinotecan and SN‐38 in patients with peritoneal metastases from colorectal origin
by: Pascale C. S. Rietveld, et al.
Published: (2024)

β-lactoglobulin-irinotecan inclusion complex as a new targeted nanocarrier for colorectal cancer cells
by: Nooshin Bijari, et al.
Published: (2019)

Oxymatrine Synergistically Enhances Doxorubicin Anticancer Effects in Colorectal Cancer
by: Di Pan, et al.
Published: (2021)

Integrated Systems Pharmacology and Surface Plasmon Resonance Approaches to Reveal the Synergistic Effect of Multiple Components of Gu-Ben-Ke-Chuan Decoction on Chronic Bronchitis
by: Luo Z, et al.
Published: (2021)

BEVACIZUMAB COMBINED WITH IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN AS THE FIRST- LINE TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA
by: Deyan Davidov
Published: (2014)

Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters
by: Esther Oyaga-Iriarte, et al.
Published: (2019)

Pharmacokinetic and Pharmacodynamic Studies of Four Major Phytochemical Components of Da-Cheng-Qi Decoction to Treat Acute Pancreatitis
by: Jianlei Zhao, et al.
Published: (2013)

ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients
by: Pau Riera, et al.
Published: (2020)

Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer
by: Wang Z, et al.
Published: (2020)

Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice Through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways
by: Min-yao Li, et al.
Published: (2020)

Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity
by: Huan-yu Guan, et al.
Published: (2017)

Quasi-MS<sup>n </sup>identification of flavanone 7-glycoside isomers in <it>Da Chengqi Tang </it>by high performance liquid chromatography-tandem mass spectrometry
by: Zhang Zunjian, et al.
Published: (2009)

Flavonoid profiling of a traditional Chinese medicine formula of Huangqin Tang using high performance liquid chromatography
by: Tao Li, et al.
Published: (2016)

Herbal pair Huangqin-Baishao: mechanisms underlying inflammatory bowel disease by combined system pharmacology and cell experiment approach
by: Xiaoqi Huang, et al.
Published: (2020)

Systematic evaluation of irinotecan-induced intestinal mucositis based on metabolomics analysis
by: Qing-Qing Yu, et al.
Published: (2022)

Gegen Qinlian standard decoction alleviated irinotecan-induced diarrhea via PI3K/AKT/NF-κB axis by network pharmacology prediction and experimental validation combination
by: Jiamei Chen, et al.
Published: (2023)

Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage
by: Di Wang, et al.
Published: (2021)

Efficacy and safety of Shengjiang Xiexin decoction on irinotecan-induced diarrhea in small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial
by: Chao Deng, et al.
Published: (2024)

Herbal Medicines for Irinotecan-Induced Diarrhea
by: Liu Tang, et al.
Published: (2019)

Sini Decoction Ameliorates Colorectal Cancer and Modulates the Composition of Gut Microbiota in Mice
by: Yishan Wang, et al.
Published: (2021)

Post-Marketing Safety Study of Ramucirumab Plus FOLFIRI: Analysis of Age and Initial Dose of Irinotecan in Patients with Metastatic Colorectal Cancer
by: Toshiki Masuishi, et al.
Published: (2023)

Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report
by: Mingming Li, et al.
Published: (2019)